Literature DB >> 1866220

Diagnostic significance of urinary growth hormone measurements in children with growth failure: correlation between serum and urine growth hormone.

C H Albini1, J Sotos, B Sherman, A Johanson, A Celniker, N Hopwood, T Quattrin, B J Mills, M H MacGillivray.   

Abstract

Twelve-h overnight urine and serum samples obtained simultaneously at 20-min intervals were assayed for growth hormone (GH). Ninety-one children, 5 to 16 y (Tanner stage 1 to 3) participated; group 1 were healthy children, group 2 were children with organic GH deficiency, and group 3 had idiopathic growth failure and normal GH stimulation tests. Serum pool GH concentrations in group 1 were similar to those in group 3 (3.3 +/- 0.3 versus 3.4 +/- 0.2 micrograms/L); group 2 had significantly lower GH concentrations (1.6 +/- 0.2 micrograms/L). Plasma IGF-I levels were significantly greater in groups 1 (14.2 +/- 2.6 nmol/L, p less than 0.001) than in groups 2 and 3 (2.6 +/- 0.5 and 5.5 +/- 0.7 nmol/L, respectively). Urinary GH (mean +/- SEM) standardized for body weight (micrograms/kg) in group 1 (0.31 +/- 0.02) was significantly greater than in group 2 (0.14 +/- 0.01) and group 3 (0.20 +/- 0.01). However, when expressed as microgram/mol creatinine, the output of GH was similar in group 1 (4.0 +/- 0.3) and group 3 (3.4 +/- 0.3); both groups had significantly greater output compared to group 2 (1.3 +/- 0.2). Urinary IGF-I (nmol/kg) in group 1 (0.22 +/- 0.02) was significantly greater than in group 2 (0.12 +/- 0.01) or group 3 (0.07 +/- 0.01). Urinary GH correlated with serum pool GH concentration (r = 0.64, p less than 0.001). Although urinary GH output reflects endogenous GH secretion, the overlap between groups 1 and 3 precludes using urinary GH measurements as a diagnostic test for GH deficiency in children with idiopathic growth failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1866220     DOI: 10.1203/00006450-199106010-00019

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

Review 1.  Screening tests for growth hormone deficiency.

Authors:  A J Evans
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

2.  Plasma and urinary GH following a standardized exercise protocol to assess GH production in short children.

Authors:  A Sartorio; E Palmieri; V Vangeli; G Conte; M Narici; G Faglia
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

3.  Concentration and Preservation of Very Low Abundance Biomarkers in Urine, such as Human Growth Hormone (hGH), by Cibacron Blue F3G-A Loaded Hydrogel Particles.

Authors:  Claudia Fredolini; Francesco Meani; K Alex Reeder; Sally Rucker; Alexis Patanarut; Palma J Botterell; Barney Bishop; Caterina Longo; Virginia Espina; Emanuel F Petricoin; Lance A Liotta; Alessandra Luchini
Journal:  Nano Res       Date:  2008-12       Impact factor: 8.897

4.  Urinary growth hormone estimation in diagnosing severe growth hormone deficiency.

Authors:  P Pirazzoli; M Mandini; S Zucchini; S Gualandi; L Vignutelli; M Capelli; E Cacciari
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

5.  Chronic growth hormone treatment in normal rats reduces post-prandial skeletal muscle plasma membrane GLUT1 content, but not glucose transport or GLUT4 expression and localization.

Authors:  R Napoli; A Cittadini; J C Chow; M F Hirshman; R J Smith; P S Douglas; E S Horton
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.